Jason Wittes Stock Analyst Profile - Roth Capital Research Coverage - Stocknear

Jason Wittes

Stock Analyst at Roth Capital

(4.35)
# 1646
Out of 5,506 analysts
64
Total ratings
Success rate
Average return

24 Stocks

Name Action PT Current % Upside Ratings Updated
SPRY ARS Pharmaceuticals
Initiates Coverage On: Buy
40
10.31 287.97% 1 Sep 4, 2025
SYK Stryker
Maintains: Strong Buy
405 456
370.6 23.04% 11 May 2, 2025
ALUR Allurion Technologie...
Reiterates: Buy
16 16
2.04 684.31% 2 Mar 21, 2025
MGRM Monogram Technologie...
Maintains: Strong Buy
4 6
6.11 -11.62% 2 Mar 18, 2025
FBIO Fortress Biotech
Reiterates: Strong Buy
15 16
2.75 481.82% 3 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
14.61 50.58% 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
60 72
71.24 1.07% 3 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
4.62 138.1% 2 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
100 115
60.48 90.15% 4 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 36
12.56 186.62% 1 Jul 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
11
7.33 50.07% 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.07 834.58% 1 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
100
87.85 13.83% 1 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.13 59.74% 4 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.69 432.54% 2 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
32.07 133.86% 2 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
13.96 57.59% 3 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
120
100.78 19.07% 7 Oct 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
206
147.29 39.86% 1 Sep 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
145
193.25 -24.97% 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
15.31 -2.02% 2 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
14.66 1264.26% 3 Feb 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
42
n/a n/a 1 Jul 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
36.7 -29.16% 1 Feb 22, 2017